|
GRCE Grace Therapeutics, Inc 1444192 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-15,790,000.00 |
| Balance Sheet |
|
Current Assets
|
$14,333,000.00 |
|
Assets
|
$50,073,000.00 |
|
Current Liabilities
|
$1,250,000.00 |
|
Liabilities
|
$1,862,000.00 |
|
Equity
|
$48,211,000.00 |
|
Shares Out
|
16274026.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,221,000.00 |
| Market Analysis |
Market Cap
|
$34,826,415.64 |
|
Price
|
$2.14 |
|
BVPS
|
2.96 |
|
PB
|
0.72 |
|
EPS
|
-0.91 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GRCE documents filed with the SEC.
GRCE Filings
Clear
